Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on whatsapp
WhatsApp

Exemasin

Exemasin is anti cancer drug indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti estrogen therapy alone.

Exemasin is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies.

Exemasin is indicated for the adjuvant treatment of postmenopausal women with estrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy

To get a personal free assessment to our service please in fill in your details and we will get back to you shortly

Improve therapeutic outcomes, prolong life and quality of life are our main business. We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics

Close Menu